New opportunities - but also economic uncertainty
With the launch of lung cancer screening (LCS) in Germany, radiology practices are facing a new opportunity: additional revenue through extrabudgetary reimbursement. In other words, practices that process more cases may also generate additional revenue.
For practices with underutilized CT capacity in particular, this creates an attractive opportunity to examine additional patients and make better use of existing infrastructure.
At the same time, key uncertainties remain:
- How many participants will actually enroll?
- How strongly will regional demand fluctuate?
- Will the investment pay off in the long term?
As a result, many practices are facing the same question: How can we participate in screening without taking on significant financial risk?



